Literature DB >> 9000854

Onychomycosis. New therapies for an old disease.

A K Gupta1, R K Scher, P De Doncker, D N Sauder, N H Shear.   

Abstract

The newer generation of antifungal agents such as itraconazole and terbinafine are more effective than the older therapies, griseofulvin and ketoconazole, in the treatment of dermatophyte pedal onychomycosis. Itraconazole can be administered as continuous dosing, 200 mg per day for 3 months, or in the form of pulse therapy, 200 mg twice a day for 1 week per month for 3 consecutive months. Terbinafine is given as continuous dosing, 250 mg per day for 3 months.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000854      PMCID: PMC1303870     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  40 in total

1.  Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview).

Authors:  M Zaug; M Bergstraesser
Journal:  Clin Exp Dermatol       Date:  1992-09       Impact factor: 3.470

2.  Continuous formation of nail along the bed.

Authors:  M Johnson; S Shuster
Journal:  Br J Dermatol       Date:  1993-03       Impact factor: 9.302

3.  A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis.

Authors:  R J Hay; Y M Clayton; W A Griffiths; P M Dowd
Journal:  Br J Dermatol       Date:  1985-06       Impact factor: 9.302

Review 4.  Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.

Authors:  M Haria; H M Bryson
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

5.  Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.

Authors:  B H Stricker; A P Blok; F B Bronkhorst; G E Van Parys; V J Desmet
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

6.  The activity of ketoconazole in the treatment of onychomycosis.

Authors:  R Galimberti; R Negroni; M R Iglesia de Elias Costa; A M Casalá
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

7.  Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.

Authors:  M H Robertson; J M Hanifin; F Parker
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

Review 8.  Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin.

Authors:  H C Korting; M Schäfer-Korting
Journal:  Arch Dermatol       Date:  1992-02

9.  Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days.

Authors:  J Faergemann; H Zehender; L Millerioux
Journal:  Clin Exp Dermatol       Date:  1994-03       Impact factor: 3.470

10.  Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.

Authors:  J Faergemann; C Anderson; K Hersle; E Hradil; P Nordin; T Kaaman; L Molin; A Pettersson
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

View more
  1 in total

1.  Onychomycosis--a different perspective.

Authors:  E Epstein
Journal:  West J Med       Date:  1997-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.